Abstract
There is a pressing clinical need to develop accurate, efficient non-contrast magnetic resonance angiography (NC-MRA) techniques. Our efforts in the field have focused on a novel non-subtractive technique called quiescent-interval slice-selective (QISS) MRA. Compared with other NC-MRA techniques, QISS has the advantage of being more accurate while enabling a simpler and more efficient workflow. The original implementation, which uses electrocardiogram (ECG) gating and a Cartesian k-space trajectory, is a reliable technique for the evaluation of peripheral arterial disease (PAD). Recent advances in QISS technology include the use of a radial k-space trajectory, which facilitates rapid imaging of the coronary, renal, and pulmonary arteries as well as other vascular beds, and ungated (“UnQISS”) acquisitions for PAD.
INTRODUCTION
Peripheral arterial disease (PAD) is a potentially debilitating manifestation of systemic atherosclerosis affecting more than 200 million people worldwide.1,2 Over the last decade, the incidence of PAD has risen globally by approximately 13% in high-income countries and 29% in low-income countries.3 Patients with PAD have a 10-year risk of death of 40%, a threefold higher risk of all-cause death, and sixfold higher risk of cardiovascular-related death than patients without PAD.4 It is associated with an increased risk of myocardial infarction, stroke, and cardiovascular-related mortality.1,2 Diabetes and smoking are the strongest risk factors for PAD. Accurate diagnosis is essential for managing the disease and confers useful prognostic information.
The availability of accurate non-invasive imaging tests has decreased the need for preoperative digital subtraction angiography (DSA) in the evaluation of PAD. The ankle brachial index (ABI) is an excellent screening test for haemodynamically significant PAD and can be performed in conjunction with Doppler waveform analysis and segmental pressure measurement to increase accuracy;5 however, its sensitivity is low in elderly patients and those with diabetes.6 Computed tomography angiography (CTA) offers high spatial resolution and short scan times without the risks associated with DSA, and is generally accurate for PAD.7,8 CTA is often acquired to provide a vascular roadmap prior to percutaneous interventional procedures; however, the clinical utility of CTA is diminished by the presence of vessel wall calcifications, associated with diabetes, heart disease, and advanced age, which cause blooming artefacts that obscure the vessel lumen.9 CTA has the further disadvantages of exposing patients to ionising radiation and the risk of contrast-induced nephropathy (CIN), which is of particular concern because nearly 40% of patients with PAD have significant renal dysfunction.10 Contrast-enhanced magnetic resonance angiography (CEMRA) has also been shown to be highly accurate for the detection of stenoses ≥50% within the lower extremity arterial tree.11,12,13 Unfortunately, the administration of gadolinium-based contrast agents in patients with severely impaired renal function is contraindicated due to the risk of nephrogenic systemic fibrosis (NSF).14 Moreover, there is growing concern about the accumulation of gadolinium chelates within the brain, the long-term consequences of which are unknown.15 This concern is exacerbated by the use of relatively high gadolinium doses for peripheral CEMRA, as well as by the potential cumulative impact when these patients have multiple CEMRA examinations during their lifetime. The use of contrast agents also increases study cost and necessitates inconvenient point-of-service renal function testing. Given these safety concerns, along with the potential cost savings involved in eliminating the need to administer a contrast agent, there is a pressing need to develop efficient non-contrast (NC)-MRA techniques that can match the accuracy of CEMRA.
EXISTING TECHNOLOGY FOR NC-MRA
Techniques for NC-MRA include electrocardiographic (ECG)-gated subtractive three-dimensional (3D) fast spin-echo (FSE) imaging such as fresh blood imaging (FBI)16 and NATIVE SPACE (NATIVE = Non-contrast Angiography of the Arteries and Veins; SPACE = Sampling Perfection with Application Optimised Contrast by using different flip angle Evolution), as well as variants predicated on 3D steady-state free precession (bSSFP), such as flow-sensitive dephasing.17 The use of image subtraction in conjunction with a time-consuming 3D acquisition makes all these techniques highly sensitive to misregistration artefact from patient motion, which is common in elderly patients who often suffer from back pain or restless legs. The problem of misregistration is particularly severe in the abdominal and pelvic regions due to breathing and bowel peristalsis. Along with the problem of misregistration, these techniques may exaggerate the severity of disease whenever the flow-sensitising gradient or the timing of the acquisition with respect to the arterial pulse wave is suboptimal. In one report using an FBI-based approach, nearly 50% of studies were non-diagnostic due to artefacts.18 Although these techniques remain promising and are under active development, none has yet proved reliable for whole-leg studies in routine clinical usage, and there is a paucity of clinical validation through multicentre trials.
QUIESCENT-INTERVAL SLICE-SELECTIVE (QISS) MRA
Over the last several years, our efforts in the field of NC-MRA have focused on a novel non-subtractive technique called QISS MRA (Fig. 1).19 Compared with subtractive approaches such as FBI and NATIVE SPACE, QISS has several advantages.20 The use of a single-shot acquisition with a very short (200–300 msec) period of data collection for each slice helps to minimise the sensitivity to patient motion compared with lengthier subtractive 3D NC-MRA techniques, where any motion during the several-minute scan may cause artefacts. Breath-holding (not practical with a subtractive 3D acquisition) can be used with QISS in the upper pelvis and abdomen to avoid respiratory artefact. Perhaps the greatest advantage is that QISS, by design, is a “push-button” technique with no need to acquire scout images, timing scans, or to make patient-specific adjustments to the imaging parameters. As a consequence, it is easy and efficient for the technologist to set up and run.
QISS has proven to be highly accurate in multiple clinical trials at both 1.5 and 3 T.21,22,23,24,25,26,27 Consequently, QISS has become a useful alternative to CEMRA and CTA, particularly in patients who have impaired renal function. In diabetic patients, QISS avoids image artefacts seen with CTA from small vessel calcifications (Fig. 2).28 If desired, peripheral vascular calcifications that are unapparent with QISS MRA can be accurately visualised through the acquisition of a separate proton density-weighted, in-phase stack of stars pulse sequence.29
Ungated QISS (UnQISS)
Compared with CTA and CEMRA, one of the potential drawbacks of QISS is its dependence on cardiac gating. Although not a concern in the majority of patients, some individuals with PAD suffer from arrhythmias that may cause artefacts on the QISS MRA. Another concern is magnetohydrodynamic interference at 3 T, which occasionally makes it difficult to obtain a reliable ECG tracing. In this subgroup of patients, none of the existing NC-MRA techniques, including FBI, flow-sensitive dephasing, QISS, or even ECG-triggered time-of-flight MRA are expected to provide diagnostic results. We therefore developed a QISS variant, which we call “UnQISS” (Figs. 3 and 4), that eliminates the need for ECG gating.30 Without ECG or pulse gating, data are acquired at random phases of the cardiac cycle. For some slices, data are acquired during periods of slow diastolic flow whereas for other slices, data are acquired during periods of rapid systolic flow. Unfortunately, the bSSFP readout is prone to severe artefacts when data are acquired during rapid flow.31 In order to overcome this limitation, recent implementations of UnQISS read out the MR signal using a novel variant on bSSFP called “fast interrupted steady-state” (FISS).32 FISS is a recently described technique in which the bSSFP readout is interrupted and spoiled at frequent intervals and data are acquired using a radial instead of a Cartesian readout. Scan time for UnQISS is about twice that for QISS, due to the need for a much longer inflow time (>1 second for UnQISS versus <300 ms for QISS), which prolongs the sequence repetition time (TR). Because of the long inflow time, a tracking inversion RF pulse is used instead of a tracking saturation RF pulse to better suppress signal from venous spins. The UnQISS technique can also be used to produce high-quality peripheral venograms. In this case, the tracking inversion is placed above the slice to suppress inflowing arterial spins, instead of below the slice.
Susceptibility artefacts
QISS uses a bSSFP pulse sequence to read out the data because of its high efficiency, signal-to-noise ratio (SNR), and intrinsic flow compensation; however, the bSSFP readout can result in severe magnetic susceptibility-related artefacts in patients with hip replacements, much worse than those seen with CEMRA. These artefacts can be greatly reduced by the use of a fast low angle shot (FLASH) readout instead of bSSFP, at the expense of lower SNR and greater flow saturation (Fig. 5).
Second-Generation QISS Techniques
The original QISS technique used a Cartesian k-space trajectory; however, for clinical applications of QISS outside of the peripheral vasculature, the use of a radial k-space trajectory offers major benefits. Radial QISS has the advantages of greatly reduced motion sensitivity33, more flexible control over temporal and spatial resolution, and support for higher undersampling factors compared with a standard Cartesian implementation. Using a Cartesian trajectory, scan time is reduced by decreasing the number of phase-encodes, which results in an undesirable decrease in spatial resolution. Alternatively, one can image faster by using parallel imaging techniques;34 however, high parallel acceleration factors cause an unacceptable increase in image noise due to spatially-dependent “geometry factor” effects. Unlike a Cartesian acquisition, spatial resolution is not degraded with a radial acquisition as the number of views is decreased so long as radial streak artefacts can be adequately suppressed. With radial QISS, streak artefacts are minimised by the suppression of background signal intensity, which is achieved through the combination of fat saturation and in-plane spatial saturation. Streak artefacts are further suppressed by sampling k-space using equidistant azimuthal view angles. With these modifications, radial QISS allows the use of higher scan accelerations than is practical with a Cartesian acquisition.
Radial QISS can be used to image the coronary arteries35, where it provides a breath-hold alternative to lengthier free-breathing, navigator-gated 3D techniques.36 For coronary imaging, radial QISS is typically acquired with two or three shots to keep temporal resolution to about 150 ms or less; this is usually sufficient to minimise artefacts from coronary motion so long as data are collected during mid to end diastole (Fig. 6). Although still in the early stages of development, potential clinical applications include localisation of the vessel origins in patients with suspected coronary anomalies and the evaluation of coronary artery disease.
In situations where very high temporal resolution is not required, such as for imaging of the renal, mesenteric or pulmonary arteries, a single-shot radial QISS acquisition allows for efficient breath-hold coverage of a vascular territory with high SNR and arterial-to-background contrast (Fig. 7).
Pulmonary embolism is a potentially lethal condition that is usually evaluated by CTA.37 Alternatively, a contrast-enhanced MRA protocol has shown potential utility for diagnosis.38 In certain patient groups, however, neither technique is entirely satisfactory. For instance, in pregnant patients, there is concern about exposing the fetus to ionising radiation with CTA, while gadolinium-based contrast agents are contraindicated. In patients with poor renal function, iodinated and gadolinium-based contrast agents should be avoided. A recent study using a single-shot, radial implementation of QISS MRA has shown promise for rapidly depicting the pulmonary arterial anatomy and can detect pulmonary embolism.39 Both breath-hold and navigator-gated acquisitions are feasible (Fig. 8). Further work is needed to determine the accuracy of this technique.
Perhaps the biggest eventual application of QISS will be for the evaluation of the cerebrovascular system and extracranial carotid arteries.40,41 The most recent version of this technique uses an ungated radial QISS acquisition with a fast-low angle shot (FLASH) readout. It can produce images that rival the quality of CEMRA and greatly surpass the quality of time-of-flight MRA techniques that are still in widespread use (Fig. 9).
CONCLUSIONS
QISS MRA has already proven to be a valuable alternative to CTA and CEMRA for the evaluation of the peripheral vasculature in patients with suspected PAD, particularly in the setting of impaired renal function. Given the technique’s high accuracy and the cost savings involved in eliminating contrast agent administration, QISS provides a viable alternative to CEMRA even in patients with normal renal function. With ongoing technical advances, such as the use of radial k-space trajectories and advanced image processing advances such as compressed sensing42, it may eventually prove to be a useful diagnostic tool for a wide range of vascular disorders.
Acknowledgments
This study was funded by NIH grants R01 HL130093, R21 HL126015, and R01 HL137920.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25:1172–1181. doi: 10.1093/ije/25.6.1172. [DOI] [PubMed] [Google Scholar]
- 2.Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110:738–743. doi: 10.1161/01.CIR.0000137913.26087.F0. [DOI] [PubMed] [Google Scholar]
- 3.Hirsch AT, Duval S. The global pandemic of peripheral artery disease. Lancet. 2013 Oct 19;382(9901):1312–4. doi: 10.1016/S0140-6736(13)61576-7. Epub 2013 Aug 1. [DOI] [PubMed] [Google Scholar]
- 4.Arain FA, Cooper LT. Peripheral arterial disease: diagnosis and management. Mayo Clin Proc. 2008;83:944–950. doi: 10.4065/83.8.944. [DOI] [PubMed] [Google Scholar]
- 5.Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic) JACC. 2006;47:1239–1312. doi: 10.1016/j.jacc.2005.10.009. [DOI] [PubMed] [Google Scholar]
- 6.Xu D, Li J, Zou L, Xu Y, Hu D, Pagoto SL, Ma Y. Sensitivity and specificity of the ankle—brachial index to diagnose peripheral artery disease: a structured review. Vasc Med. 2010;15:361–369. doi: 10.1177/1358863X10378376. [DOI] [PubMed] [Google Scholar]
- 7.Hessel SJ, Adams DF, Abrams HL. Complications of angiography. Radiology. 1981;138:273–281. doi: 10.1148/radiology.138.2.7455105. [DOI] [PubMed] [Google Scholar]
- 8.Catalano C, Fraioli F, Laghi A, et al. Infrarenal aortic and lower-extremity arterial disease: diagnostic performance of multi-detector row CT angiography. Radiology. 2004;231:555–563. doi: 10.1148/radiol.2312020920. [DOI] [PubMed] [Google Scholar]
- 9.Ouwendijk R, Kock MC, van Dijk LC, van Sambeek MR, Stijnen T, Hunink MG. Vessel wall calcifications at multi-detector row CT angiography in patients with peripheral arterial disease: effect on clinical utility and clinical predictors. Radiology. 2006;241:603–608. doi: 10.1148/radiol.2412050781. [DOI] [PubMed] [Google Scholar]
- 10.Tranche-Iparraguirre S, Marín-Iranzo R, Fernández-de Sanmamed R, Riesgo-García A, Hevia-Rodríguez E, García-Casas JB. Peripheral arterial disease and kidney failure: a frequent association. Nefrologia. 2012 May 14;32(3):313–20. doi: 10.3265/Nefrologia.pre2011.Nov.11172. Epub 2012 Jan 27. [DOI] [PubMed] [Google Scholar]
- 11.Menke J, Larsen J. Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease. Ann Intern Med. 2010;153:325–334. doi: 10.7326/0003-4819-153-5-201009070-00007. [DOI] [PubMed] [Google Scholar]
- 12.Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group. JAMA. 1995;274:875–880. [PubMed] [Google Scholar]
- 13.Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis. JAMA. 2001;285:1338–1345. doi: 10.1001/jama.285.10.1338. [DOI] [PubMed] [Google Scholar]
- 14.Prince MR, Zhang H, Morris M, et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology. 2008;248:807–816. doi: 10.1148/radiol.2483071863. [DOI] [PubMed] [Google Scholar]
- 15.Olchowy C, Cebulski K, Łasecki M, et al. The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity — a systematic review. PLoS ONE. 2017;12(2):e0171704. doi: 10.1371/journal.pone.0171704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Miyazaki M, Takai H, Sugiura S, Wada H, Kuwahara R, Urata J. Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Radiology. 2003;227:890–896. doi: 10.1148/radiol.2273020227. [DOI] [PubMed] [Google Scholar]
- 17.Fan Z, Sheehan J, Bi X, Liu X, Carr J, Li D, et al. 3D noncontrast MR angiography of the distal lower extremities using flow-sensitive dephasing (FSD)-prepared balanced SSFP. Magn Reson Med. 2009;62:1523–1532. doi: 10.1002/mrm.22142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lim RP, Hecht EM, Xu J, Babb JS, et al. 3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience. J Magn Reson Imag. 2008;28:181–189. doi: 10.1002/jmri.21416. [DOI] [PubMed] [Google Scholar]
- 19.Edelman RR, Sheehan JJ, Dunkle E, Schindler N, Carr J, Koktzoglou I. Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: technical considerations and clinical feasibility. Magn Reson Med. 2010;63:951–958. doi: 10.1002/mrm.22287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ward EV, Galizia MS, Usman A, Popescu AR, Dunkle E, Edelman RR. Comparison of quiescent inflow single-shot and native space for nonenhanced peripheral MR angiography. J Magn Reson Imaging. 2013;38(6):1531–1538. doi: 10.1002/jmri.24124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hodnett PA, Koktzoglou I, Davarpanah AH, et al. Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single shot MR angiography. Radiology. 2011;260:282–293. doi: 10.1148/radiol.11101336. R01 HL096916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Klasen J, Blondin D, Schmitt P, et al. Nonenhanced ECG-gated quiescent-interval single-shot MRA (QISS-MRA) of the lower extremities: comparison with contrast-enhanced MRA. Clin Radiol. 2012;67:441–446. doi: 10.1016/j.crad.2011.10.014. [DOI] [PubMed] [Google Scholar]
- 23.Hansmann J, Morelli JN, Michaely HJ, Riester T, Budjan J, Schoenberg SO, Attenberger UI. Nonenhanced ECG-gated quiescent-interval single shot MRA: image quality and stenosis assessment at 3 tesla compared with contrast-enhanced MRA and digital subtraction angiography. J Magn Reson Imaging. 2014;39:1486–1493. doi: 10.1002/jmri.24324. [DOI] [PubMed] [Google Scholar]
- 24.Knobloch G, Gielen M, Lauff MT, et al. ECG-gated quiescent-interval single-shot MR angiography of the lower extremities: initial experience at 3 T. Clin Radiol. 2014;69(5):485–491. doi: 10.1016/j.crad.2013.12.006. [DOI] [PubMed] [Google Scholar]
- 25.Thierfelder KM, Meimarakis G, Nikolaou K, et al. Non-contrast-enhanced MR angiography at 3 Tesla in patients with advanced peripheral arterial occlusive disease. PLoS One. 2014;9(3):e91078. doi: 10.1371/journal.pone.0091078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Amin P, Collins JD, Koktzoglou I, et al. Evaluating peripheral arterial disease with unenhanced quiescent-interval single-shot MR angiography at 3 T. AJR Am J Roentgenol. 2014;202(4):886–893. doi: 10.2214/AJR.13.11243. [DOI] [PubMed] [Google Scholar]
- 27.Mustafa MA, Jaskolka JJ, Tan K, et al. Non-contrast-enhanced MR angiography in critical limb ischemia: performance of quiescent-interval single-shot (QISS) and TSE-based subtraction techniques. Eur Radiol. 2017;27:1218–1226. doi: 10.1007/s00330-016-4448-6. [DOI] [PubMed] [Google Scholar]
- 28.Hodnett PA, Ward EV, Davarpanah AH, et al. Peripheral arterial disease in a symptomatic diabetic population: prospective comparison of rapid unenhanced MR angiography (MRA) with contrast-enhanced MRA. AJR Am J Roentgenol. 2011;197:1466–73. doi: 10.2214/AJR.10.6091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Ferreira Botelho MP, Koktzoglou I, Collins JD, et al. MR imaging of iliofemoral peripheral vascular calcifications using proton density-weighted, in-phase three-dimensional stack-of-stars gradient echo. Magn Reson Med. 2017 Jun;77(6):2146–2152. doi: 10.1002/mrm.26295. Epub 2016 Jun 14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Edelman RR, Giri S, Murphy IG, Flanagan O, Speier P, Koktzoglou I. Ungated radial quiescent-inflow single-shot (UnQISS) magnetic resonance angiography using optimized azimuthal equidistant projections. Magn Reson Med. 2014;72:1522–1529. doi: 10.1002/mrm.25477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Markl M, Alley MT, Elkins CJ, Pelc NJ. Flow effects in balanced steady state free precession imaging. Magn Reson Med. 2003 Nov;50(5):892–903. doi: 10.1002/mrm.10631. [DOI] [PubMed] [Google Scholar]
- 32.Koktzoglou I, Edelman RR. Radial fast interrupted steady-state (FISS) magnetic resonance imaging. Magn Reson Med. 2017 Aug 30; doi: 10.1002/mrm.26881. Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Glover GH, Pauly JM. Projection reconstruction techniques for reduction of motion effects in MRI. Magn Reson Med. 1992;28(2):275–289. doi: 10.1002/mrm.1910280209. [DOI] [PubMed] [Google Scholar]
- 34.Deshmane A, Gulani V, Griswold MA, Seiberlich N. Parallel MR imaging. J Magn Reson Imaging. 2012 Jul;36(1):55–72. doi: 10.1002/jmri.23639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Edelman RR, Giri S, Pursnani A, Botelho MPF, Li W, Koktzoglou I. Breath-hold imaging of the coronary arteries using quiescent-interval slice-selective (QISS) magnetic resonance angiography: pilot study at 1.5 Tesla and 3 Tesla. J Cardiovasc Magn Reson. 2015 Nov;17:101. doi: 10.1186/s12968-015-0205-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kato S, Kitagawa K, Ishida N, et al. Assessment of coronary artery disease using magnetic resonance coronary angiography: a national multicenter trial. J Am Coll Cardiol. 2010 Sep 14;56(12):983–91. doi: 10.1016/j.jacc.2010.01.071. [DOI] [PubMed] [Google Scholar]
- 37.Lapner ST, Kearon C. Diagnosis and management of pulmonary embolism. BMJ. 2013 Feb 20;346:f757. doi: 10.1136/bmj.f757. [DOI] [PubMed] [Google Scholar]
- 38.Nagle SK, Schiebler ML, Repplinger MD, et al. Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: building a successful program. Eur J Radiol. 2016 Mar;85(3):553–563. doi: 10.1016/j.ejrad.2015.12.018. Epub 2015 Dec 29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Edelman RR, Silvers RI, Thakrar KH, et al. Nonenhanced MR angiography of the pulmonary arteries using single-shot radial quiescent-interval slice-selective (QISS): a technical feasibility study. J Cardiovasc Magn Reson. 2017 Jun 30;19(1):48. doi: 10.1186/s12968-017-0365-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Koktzoglou I, Murphy IG, Giri S, Edelman RR. Quiescent interval low angle shot magnetic resonance angiography of the extracranial carotid arteries. Magn Reson Med. 2016 May;75(5):2072–7. doi: 10.1002/mrm.25791. Epub 2015 Jun 15. [DOI] [PubMed] [Google Scholar]
- 41.Koktzoglou I, Edelman RR. Super-resolution intracranial quiescent interval slice-selective magnetic resonance angiography. Magn Reson Med. 2017 May 3; doi: 10.1002/mrm.26715. Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Akçakaya M, Hu P, Chuang ML, et al. Accelerated noncontrast-enhanced pulmonary vein MRA with distributed compressed sensing. J Magn Reson Imaging. 2011 May;33(5):1248–55. doi: 10.1002/jmri.22559. [DOI] [PMC free article] [PubMed] [Google Scholar]